Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,288 | 33,572 | 38,647 | 7,438 | -17,112 |
| Depreciation Amortization | 1,071 | 5,205 | 5,386 | 3,285 | 1,808 |
| Income taxes - deferred | 3,877 | N/A | 0 | N/A | 0 |
| Accounts receivable | 479 | 187 | -955 | -54 | -36 |
| Other Working Capital | 1,475 | -741 | -1,060 | 773 | 1,031 |
| Other Operating Activity | -64,288 | -80,549 | -75,492 | -36,001 | -4 |
| Operating Cash Flow | $-8,098 | $-42,326 | $-33,474 | $-24,559 | $-14,313 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215 | -2,526 | -2,104 | -1,662 | -850 |
| Net Acquisitions | N/A | -8,376 | -8,376 | -8,376 | N/A |
| Other Investing Activity | -8,939 | 13 | 0 | 22 | -815 |
| Investing Cash Flow | $-9,154 | $-10,889 | $-10,480 | $-10,016 | $-1,665 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 123 | 1,757 | 1,150 | 1,019 | 0 |
| Debt Repayment | -31 | -145 | -104 | -74 | -17 |
| Common Stock Issued | 20,150 | 32,997 | 32,861 | 19,686 | 214 |
| Other Financing Activity | -1,145 | -1,827 | -1,968 | -900 | 567 |
| Financing Cash Flow | $19,097 | $32,782 | $31,939 | $19,731 | $764 |
| Exchange Rate Effect | -117 | 292 | 237 | 317 | 117 |
| Beginning Cash Position | 22,935 | 42,229 | 42,229 | 42,229 | 42,229 |
| End Cash Position | 24,663 | 22,088 | 30,451 | 27,702 | 27,132 |
| Net Cash Flow | $1,728 | $-20,141 | $-11,778 | $-14,527 | $-15,097 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,098 | -42,326 | -33,474 | -24,559 | -14,313 |
| Capital Expenditure | -215 | -2,526 | -2,138 | -1,662 | -850 |
| Free Cash Flow | -8,313 | -44,852 | -35,612 | -26,221 | -15,163 |